| Patient | Nikola Tesla |
|---|---|
| Date of birth | 1856-07-10 |
| Identifiers | MRN HR-NI009-SYN-TD; SSN (made up) 000-09-7408 |
| Document date | 1902-06-30 |
| Author | Branimir Kovač-Holt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twenty-four-week OCD treatment review. [S]
Mr. Tesla returns twelve weeks after the increase to sertraline 150 mg. At the nurse telephone check two weeks after the increase he reported mild sweating and no other side effects. He now has mild delayed ejaculation, which he finds acceptable, and has missed no doses. The Y-BOCS his therapist was to rate at about week eighteen was not done: that session was spent on an exposure at his laboratory and no rating was rescheduled. He has had eighteen ERP sessions and will finish the course next month. His rituals take about 45 minutes a day; he still counts steps on some walks but can stop. He eats three meals a day without calculating, sleeps about six hours, and has stopped working after midnight. He has had no suicidal thoughts. [S]
| Element | Detail |
|---|---|
| Missed rating | Therapist's Y-BOCS at about week eighteen not done |
| Sertraline | Mild sweating and delayed ejaculation; no missed doses |
| Rituals | About 45 minutes a day |
| Nutrition and sleep | Three meals a day; about six hours of sleep |
| Safety | No suicidal thoughts |
| Y-BOCS | 13, down from 28 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight up 3.1 kg since intake; energy good |
| Genitourinary | Positive | Mild delayed ejaculation on sertraline |
| Integumentary | Negative | Hands normal; mild sweating |
| Psychiatric | Negative | Obsessions infrequent and brief; mood good; no suicidal thoughts |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1902-01-13 to 1902-02-24 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1902-02-24 to 1902-04-07 | completed | S |
| Sertraline 50 mg oral tablet, three tablets (150 mg) by mouth each morning | Three tablets by mouth each morning | Oral route | 1902-04-07 | active | S |
| White petrolatum ointment, apply to both hands after each wash and at bedtime | Apply a thin layer to both hands after washing and at bedtime | Topical route | 1902-01-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1902-06-30 | Body height | 188 | cm | S |
| 1902-06-30 | Body weight | 66.9 | kg | S |
| 1902-06-30 | Body mass index (BMI) [Ratio] | 18.9 | kg/m2 | S |
| 1902-06-30 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1902-06-30 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1902-06-30 | Heart rate | 66 | /min | S |
| 1902-06-30 | Respiratory rate | 14 | /min | S |
| 1902-06-30 | Body temperature | 36.6 | Cel | S |
| 1902-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1902-06-30 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1902-06-30 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 1902-06-30 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 412 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1902-06-30 | Albumin [Mass/volume] in Serum or Plasma | 4.2 | g/dL | 3.5-5 g/dL | Normal | S |
Vital signs recorded on 1902-06-30; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Slim, relaxed, and animated |
| Mental status | Articulate and humorous; mood "like a weight lifted"; affect full; good insight; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Obsessive-compulsive disorder, severe (Y-BOCS 28), with good insight: contamination, symmetry, and number obsessions; washing, counting, repeating in threes, and calculating compulsions; synthetic modern diagnosis linked to his own accounts of counting and calculating rituals and aversions | active | confirmed | F42.2 | S — Synthetic modern diagnosis. His rituals and aversions are documented in his own words (D); calling them obsessive-compulsive disorder is a retrospective interpretation (R), and no diagnosis was made in his lifetime. |
| Irritant contact dermatitis of both hands from washing them 40 to 60 times a day | resolved | confirmed | L24.9 | S — Synthetic consequence of washing compulsions. |
| Underweight (BMI 18.1) with about 4 kg weight loss over six months, from skipped meals and food-calculating rituals | resolved | confirmed | R63.6 | S — Synthetic nutritional consequence echoing his documented habit of calculating the volume of food before eating. |
| Insufficient sleep, four hours a night, from late work and night-time rituals | resolved | confirmed | Z72.820 | S — Synthetic sleep problem echoing his documented claims about very short sleep. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Y-BOCS severity score (recorded in the note; no LOINC code found) | At baseline and about every 4 to 6 weeks during acute treatment | Completed today | 13, down 54 percent from 28: response |
| Survey | Interim Y-BOCS between the twelve-week review and today | At baseline and about every 4 to 6 weeks during acute treatment | Deferred | Not done, a deviation from the protocol: the therapist's Y-BOCS planned at about week eighteen was not done because that session was used for an exposure and no rating was rescheduled, leaving twelve weeks without a severity score during the titration. No harm resulted judging by today's score and review: he responded and had no suicidal thoughts. Corrective action: the therapist now enters a Y-BOCS in the shared record every sixth session, and the clinic registry flags a missing score |
| Survey | PHQ-9 and GAD-7 for secondary depression and anxiety | At baseline and periodically while depressive or anxiety symptoms are present | Completed today | PHQ-9 3 (item 9 scored 0); GAD-7 5 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given) | Every visit during acute treatment | Completed today | No suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Protective factors stronger than at intake. Safety plan reviewed |
| Medication safety | Sertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects) | Every visit and two weeks after each dose increase | Completed today | Nurse call two weeks after the increase: mild sweating only. Today mild delayed ejaculation, acceptable to him; no missed doses |
| Self-management | Exposure and response prevention attendance and homework | Every visit during acute treatment | Completed today | Eighteen sessions; course ends next month; booster sessions planned |
| Examination | Weight and BMI | Every visit while underweight | Completed today | 66.9 kg, BMI 18.9, up 3.1 kg since intake |
| Laboratory | Albumin and vitamin B12 after dietary change | Once, after about six months of better intake | Completed today | Albumin 4.2 g/dL; vitamin B12 412 pg/mL |
| Self-management | Sleep diary | Every visit during acute treatment | Completed today | About six hours a night |
| Medication safety | Antipsychotic augmentation monitoring (weight, glucose, lipids, movement) | Only if an antipsychotic is added | Not indicated | No augmentation; responding to sertraline and ERP |
Goal progress:
Guideline basis: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Preventive visit in October; OCD review in about three months. Next scheduled visit 1902-10-13: periodic adult preventive visit. [S]